Besides ERBB2, other genes encoding receptor tyrosine kinases or downstream proteins of their pathways are recurrently amplified, albeit in lower frequencies, in gastrointestinal cancers, such as gastric, esophageal, and colorectal carcinomas [39]. This evidence concerns the gene ERBB2 and colorectal carcinoma.